Estimate Recalculated Nov 1, 2024 10:20AM EST
Alan Lotvin has an estimated net worth of $18.3 Million. This is based on reported shares across multiple companies, which include CVS HEALTH Corp, MAGELLAN HEALTH SERVICES INC, and PROKIDNEY CORP..
Alan Lotvin's CIK is 0001472795
2022 was Alan Lotvin's most active year for acquiring shares with 8 total transactions. Alan Lotvin's most active month to acquire stocks was the month of February. 2011 was Alan Lotvin's most active year for disposing of shares, totalling 9 transactions. Alan Lotvin's most active month to dispose stocks was the month of March. 2021 saw Alan Lotvin paying a total of $10,702,188.44 for 242,445 shares, this is the most they've acquired in one year. In 2022 Alan Lotvin cashed out on 367,781 shares for a total of $20,324,392.84, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Form 4 | -41.79% | -143.44K | $78.22 | -$5.95M | Aug 05, 2022 | 496.04K | Sale | Scheduled | Aug 03 - Aug 04 |
Form 4 | 27.04% | 39.83K | $101.09 | $4.03M | Apr 05, 2022 | 633.48K | Grant | — | Apr 01 |
Form 4 | 140.15% | 85.97K | — | — | Feb 23, 2022 | 599.48K | Grant | — | Feb 21 |
Form 4 | -25.85% | -21.39K | $104.38 | -$90.63K | Feb 02, 2022 | 513.35K | Sale | Scheduled | Feb 01 |
Form 4 | -3.32% | -200.00 | $88.78 | -$17.76K | Dec 28, 2021 | 534.74K | Tax | — | Dec 27 |
Form 4 | -4.36% | -2.78K | $83.67 | -$232.69K | Jun 29, 2021 | 534.30K | Sale | Scheduled | Jun 28 |
Form 4 | -2.60% | -1.71K | $74.30 | -$126.68K | Apr 05, 2021 | 536.90K | Tax | — | Apr 03 |
Form 4 | 2,060.63% | 174.18K | $74.30 | $8.99M | Apr 02, 2021 | 538.60K | Grant | — | Feb 01 - Apr 01 |
Form 4 | -24.63% | -25.84K | $70.72 | -$221.35K | Jan 12, 2021 | 364.10K | Sale | Scheduled | Jan 08 |
Form 4 | -47.08% | -7.14K | $70.00 | -$499.66K | Nov 17, 2020 | 47.47K | Sale | Scheduled | Nov 13 |
Form 4 | 49.21% | 5.00K | $63.14 | $315.68K | May 13, 2020 | 54.04K | Purchase | — | May 11 |
Form 4/A | — | 140.80K | — | — | Apr 07, 2020 | 140.80K | Grant | — | Apr 01 |
Form 4 | 1,196.63% | 139.32K | $58.48 | $8.17M | Apr 03, 2020 | 391.03K | Grant | — | Apr 01 |
Form 4 | 47.47% | 11.67K | $59.18 | $690.51K | Mar 03, 2020 | 50.39K | Grant | — | Feb 28 |
Form 4 | 947.00% | 79.94K | $54.19 | $4.33M | Apr 03, 2019 | 238.59K | Grant | — | Apr 01 |
Form 4 | 41.44% | 6.05K | $57.83 | $349.87K | Mar 01, 2019 | 38.68K | Grant | — | Feb 28 |
Form 3 | — | — | — | — | Jun 08, 2018 | 32.10K | — | — | — |
Form 4 | -60.74% | -1.22K | $46.96 | -$18.15K | May 02, 2011 | 786.00 | Sale | Scheduled | Apr 28 |
Form 4 | -46.48% | -7.46K | $41.41 | -$126.71K | Apr 05, 2011 | 8.59K | Sale | Scheduled | Apr 04 |
Form 4 | -15.00% | -302.00 | $48.74 | -$14.72K | Apr 05, 2011 | 1.71K | Options | — | Mar 04 |
Form 4 | 222.47% | 198.00 | $48.10 | -$2.02K | Mar 09, 2011 | 287.00 | Options | — | Mar 05 |
Form 4 | 222.47% | 198.00 | $48.10 | -$2.02K | Mar 09, 2011 | 287.00 | Options | — | Mar 05 |
Form 4 | -38.88% | -10.53K | $41.87 | -$178.21K | Nov 10, 2010 | 16.56K | Sale | Scheduled | Nov 08 |
Form 4 | 19.54% | 197.00 | $43.34 | -$1.95K | Mar 09, 2010 | 1.21K | Options | — | Mar 05 |
Form 4 | 105.41% | 1.40K | $42.57 | -$13.79K | Mar 08, 2010 | 2.74K | Options | — | Mar 04 |
Form 3 | — | — | — | — | Sep 24, 2009 | 469.00 | — | — | — |
Form 4 | — | 62.56K | — | — | Jun 03, 2024 | 62.56K | Grant | — | May 30 |
Form 4 | — | 48.13K | — | — | Jul 03, 2023 | 48.13K | Grant | — | Jun 29 |
Form 4 | — | 3.03M | — | — | Jul 13, 2022 | 3.03M | Grant | — | Jul 11 |
Form 3 | — | — | — | — | Jul 13, 2022 | — | — | — | — |